Skip to content

A randomized controlled study on the effectiveness of Peiyuan Tongbi Plaster Mofa in treating patients with knee osteoarthritis

A randomized controlled study on the effectiveness of Peiyuan Tongbi Plaster Mofa in treating patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075829
Enrollment
Unknown
Registered
2023-09-16
Start date
2023-09-16
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

placebo treatment group:Placebo, manual therapy
Peiyuan Tongbi Plaster treatment group:Peiyuan Tongbi Plaster, manual therapy

Sponsors

Xinjiang Uygur autonomous region hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The included cases were diagnosed according to the diagnostic criteria for knee osteoarthritis in the Chinese Journal of Orthopedics, Volume 38, Issue 12, June 2018. 2. Age range from 50 to 70 years old. 3. Sign the informed consent form (see Appendix F). 4. Not taking hormones or other medications to treat this disease 4 weeks before treatment.

Exclusion criteria

Exclusion criteria: 1. Serious diseases of knee joint, such as tuberculosis and tumor of knee joint, infectious diseases of knee joint, such as suppurative knee arthritis or osteomyelitis, knee joint trauma, such as meniscus injury of knee joint; Patients with knee ligament injury, skin damage around the joint, and vascular and nerve injury. 2. Severe symptoms in the respiratory system, cardiovascular system, hematopoietic system, digestive system, or nervous system patients who are unable to undergo normal massage treatment due to illness. 3. Patients who are pregnant or breastfeeding after giving birth. 4. Patients who are allergic to the experimental drug ointment used or have an allergic constitution themselves. 5. Patients who participate in other project group experiments without the permission of the researcher. 6. Patients who do not comply with experimental requirements and refuse to cooperate. 7. Patients with other uncontrollable factors.

Design outcomes

Primary

MeasureTime frame
Visual analogu scale (VAS) score;The Western Ontario and McMaster Universities (WOMAC) scale;Plantar pressure detection;

Countries

China

Contacts

Public ContactXue Bai

Xinjiang Uygur autonomous region hospital of Traditional Chinese Medicine

369006459@qq.com+86 177 9916 5619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026